Heli Harvala1, Michael Griffiths2, Tom Solomon2, Peter Simmonds3. 1. Specialist Virology Laboratory, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK; Infection and Immunity Division, Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh EH25 9RG, UK. Electronic address: heli.simmonds@hotmail.com. 2. The Institute of Infection and Global Health, The Ronald Ross Building, University of Liverpool, Liverpool L69 7BE, UK. 3. Infection and Immunity Division, Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh EH25 9RG, UK.
Abstract
OBJECTIVES: Enteroviruses (EV) and human parechoviruses (HPeV) infections are increasingly identified in neonates and young children with sepsis, meningitis and encephalitis. We investigated EV and HPeV viral loads in plasma and cerebrospinal fluid (CSF) among those presenting with sepsis or central nervous system (CNS) disease to gain understanding of the nature of these infections. METHODS: Detections frequencies and viral loads of EV and HPeV RNA were compared in plasma and CSF obtained from infected children originally identified on sepsis or CNS screening. RESULTS: Two distinct infection profiles were identified; 11 subjects with CNS disease, showed higher or similar viral loads in CSF than in plasma (median plasma:CSF ratio 0.5), whereas 14 children with sepsis showed low or undetectable viral loads in CSF and high viral loads in plasma (mean ratio 5700). HPeV type 3 and one EV serotype (coxsackievirus B2) were primarily associated with the latter presentation. CONCLUSIONS: Simple detection of EV or HPeV RNA in CSF is not predictive of CNS disease, especially in the absence of clinical markers (i.e. pleocytosis). Screening of plasma can identify EV and HPeV RNA in a substantial proportion of sepsis cases, some of which will be missed if CSF samples alone are screened.
OBJECTIVES: Enteroviruses (EV) and human parechoviruses (HPeV) infections are increasingly identified in neonates and young children with sepsis, meningitis and encephalitis. We investigated EV and HPeV viral loads in plasma and cerebrospinal fluid (CSF) among those presenting with sepsis or central nervous system (CNS) disease to gain understanding of the nature of these infections. METHODS: Detections frequencies and viral loads of EV and HPeV RNA were compared in plasma and CSF obtained from infected children originally identified on sepsis or CNS screening. RESULTS: Two distinct infection profiles were identified; 11 subjects with CNS disease, showed higher or similar viral loads in CSF than in plasma (median plasma:CSF ratio 0.5), whereas 14 children with sepsis showed low or undetectable viral loads in CSF and high viral loads in plasma (mean ratio 5700). HPeV type 3 and one EV serotype (coxsackievirus B2) were primarily associated with the latter presentation. CONCLUSIONS: Simple detection of EV or HPeV RNA in CSF is not predictive of CNS disease, especially in the absence of clinical markers (i.e. pleocytosis). Screening of plasma can identify EV and HPeV RNA in a substantial proportion of sepsis cases, some of which will be missed if CSF samples alone are screened.
Authors: H Rudolph; R Prieto Dernbach; M Walka; P Rey-Hinterkopf; V Melichar; E Muschiol; S Schweitzer-Krantz; J W Richter; C Weiss; S Böttcher; S Diedrich; H Schroten; T Tenenbaum Journal: Eur J Clin Microbiol Infect Dis Date: 2017-04-13 Impact factor: 3.267
Authors: Herbert Kurz; Ruth Prammer; Wolfgang Bock; Robert Ollerieth; Günther Bernert; Karl Zwiauer; Judith H Aberle; Stephan W Aberle; Tamas Fazekas; Wolfgang Holter Journal: Eur J Pediatr Date: 2015-06-25 Impact factor: 3.860
Authors: María Cabrerizo; Gloria Trallero; María José Pena; Amaia Cilla; Gregoria Megias; Carmen Muñoz-Almagro; Eva Del Amo; Diana Roda; Ana Isabel Mensalvas; Antonio Moreno-Docón; Juan García-Costa; Nuria Rabella; Manuel Omeñaca; María Pilar Romero; Sara Sanbonmatsu-Gámez; Mercedes Pérez-Ruiz; María José Santos-Muñoz; Cristina Calvo Journal: Eur J Pediatr Date: 2015-05-16 Impact factor: 3.183
Authors: M L A May; S Tozer; R Day; R Doyle; A Bernard; L J Schlapbach; C Heney; J E Clark; S Bialasiewicz Journal: Mol Biol Rep Date: 2019-10-28 Impact factor: 2.742
Authors: Silke Vollbach; Andreas Müller; Jan Felix Drexler; Arne Simon; Christian Drosten; Anna Maria Eis-Hübinger; Marcus Panning Journal: Virol J Date: 2015-11-25 Impact factor: 4.099
Authors: Hans de Graaf; Emanuela Pelosi; Andrea Cooper; John Pappachan; Kim Sykes; Iain MacIntosh; Diane Gbesemete; Tristan W Clark; Sanjay V Patel; Saul N Faust; Marc Tebruegge Journal: Pediatr Infect Dis J Date: 2016-07 Impact factor: 2.129